SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Ambev S.A. (ABEV) trades at a trailing P/E of 16.0, forward P/E of 3.1. Trailing earnings yield is 6.24%, forward earnings yield 32.36%. PEG 1.82. Graham Number is $11.28.
Criteria proven by this page:
- VALUE (48/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 3.1 (down from trailing 16.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.82 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 6.24% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 32.36% as earnings recover.
- Analyst consensus target $2.94 (-6.4% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 63/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
48/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ABEV
Valuation Multiples
P/E (TTM)16.0
Forward P/E3.1
PEG Ratio1.82
Forward PEG1.24
P/B Ratio2.83
P/S Ratio2.82
EV/EBITDA8.3
Per Share Data
EPS (TTM)$0.99
Forward EPS (Est.)$1.02
Book Value / Share$5.69
Revenue / Share$5.66
FCF / Share$1.27
Yields & Fair Value
Earnings Yield6.24%
Forward Earnings Yield32.36%
Dividend Yield5.94%
Graham Number$11.28
SharesGrow IV$7.97 (+153.8%)
Analyst Target$2.94 (-6.4%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
20.0 |
15.79 |
5.59 |
5.50 |
4.12% |
| 2017 |
47.2 |
-1.15 |
7.53 |
7.17 |
2.57% |
| 2018 |
21.7 |
0.44 |
4.25 |
4.76 |
3.69% |
| 2019 |
24.9 |
3.49 |
4.79 |
5.64 |
2.68% |
| 2020 |
22.0 |
-5.49 |
3.39 |
4.28 |
2.74% |
| 2021 |
19.4 |
1.55 |
2.97 |
3.37 |
4.53% |
| 2022 |
15.6 |
1.15 |
2.76 |
2.84 |
5.41% |
| 2023 |
14.8 |
0.00 |
2.73 |
2.70 |
5.54% |
| 2024 |
12.6 |
0.00 |
1.84 |
2.03 |
2.24% |
| 2025 |
13.6 |
1.79 |
2.40 |
2.39 |
9.69% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.79 |
$45.6B |
$12.55B |
27.5% |
| 2017 |
$0.47 |
$47.9B |
$7.33B |
15.3% |
| 2018 |
$0.70 |
$50.23B |
$11.02B |
21.9% |
| 2019 |
$0.74 |
$52.6B |
$11.78B |
22.4% |
| 2020 |
$0.72 |
$58.38B |
$11.38B |
19.5% |
| 2021 |
$0.80 |
$72.85B |
$12.67B |
17.4% |
| 2022 |
$0.91 |
$79.71B |
$14.46B |
18.1% |
| 2023 |
$0.92 |
$79.74B |
$14.5B |
18.2% |
| 2024 |
$0.91 |
$89.45B |
$14.44B |
16.1% |
| 2025 |
$0.99 |
$88.24B |
$15.5B |
17.6% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.01 |
$0.95 – $1.05 |
$90.93B |
$87.62B – $94.06B |
4 |
| 2027 |
$1.08 |
$1.03 – $1.13 |
$95.4B |
$91.93B – $98.69B |
3 |
| 2028 |
$1.13 |
$1.08 – $1.18 |
$100.19B |
$96.54B – $103.64B |
1 |
| 2029 |
$1.45 |
$1.38 – $1.51 |
$108.93B |
$104.97B – $112.69B |
1 |
| 2030 |
$1.60 |
$1.52 – $1.67 |
$115.5B |
$111.29B – $119.48B |
1 |
